£900K
TwinPath Ventures led the pre-seed round to help accelerate regulatory clearance and clinical validation for the company's sepsis prediction software.
AM
Aisthesis Medical
Aisthesis Medical develops hospital-grade artificial intelligence software to predict and prevent life-threatening clinical conditions.
United Kingdom—Founded 2022
£900KTotal raised
Aisthesis Medical develops hospital-grade artificial intelligence software designed to predict and prevent life-threatening medical conditions. Its primary platform, VIOSync SPI, helps clinicians anticipate in-hospital sepsis development.
Categories
Founders
IG
Ioannis Gkouzionis
Co-founder & CEO
VD
Vasilis Dimakopoulos
SL
Sotiris Liliopoulos